- Trials with a EudraCT protocol (186)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
186 result(s) found for: Implant Failure.
Displaying page 1 of 10.
EudraCT Number: 2013-003940-21 | Sponsor Protocol Number: 46361 | Start Date*: 2014-03-20 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Systemic antibiotic therapy (amoxicillin plus metronidazole) as an adjunct to surgical treatment of peri-implantitis; a single blind randomized controlled study | ||
Medical condition: peri-implantitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002168-42 | Sponsor Protocol Number: 20052017 | Start Date*: 2018-12-18 |
Sponsor Name:Iciar Arteagoitia Calvo | ||
Full Title: Efficacy of clindamycin in preventing infection and failure after dental implant placement: a placebo-controlled randomized clinical trial. | ||
Medical condition: Healthy volunteers (Postoperative infections and dental implant failures) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000294-33 | Sponsor Protocol Number: LX201-02 | Start Date*: 2007-07-27 | |||||||||||
Sponsor Name:Lux Biosciences, Inc. | |||||||||||||
Full Title: A MULTI-CENTER, PLACEBO-CONTROLLED, RANDOMIZED, PARALLEL-GROUP, DOSE-RANGING STUDY TO ASSESS THE EFFICACY AND SAFETY OF LX201 IMPLANTATION FOR THE PREVENTION OF CORNEAL ALLOGRAFT REJECTION EPISODES... | |||||||||||||
Medical condition: Patient after penetrating keratoplasty who have experienced one or more rejection episodes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000295-16 | Sponsor Protocol Number: LX201-01 | Start Date*: 2007-07-27 | |||||||||||
Sponsor Name:Lux Biosciences, Inc. | |||||||||||||
Full Title: A MULTI-CENTER, PLACEBO-CONTROLLED, RANDOMIZED, PARALLEL-GROUP DOSE-RANGING STUDY TO ASSESS THE EFFICACY AND SAFETY OF LX201 FOR PREVENTION OF CORNEAL ALLOGRAFT REJECTION EPISODES AND GRAFT FAILURE... | |||||||||||||
Medical condition: Patient after penetrating keratoplasty who are at increased immunological risk for corneal allograft rejection episodes and/or graft failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002118-37 | Sponsor Protocol Number: HTAJ-TRANEX-2019-01 | Start Date*: 2021-06-17 |
Sponsor Name:Rafael Blancas-Gómez Casero | ||
Full Title: MULTICENTER, DOUBLE BLIND CLINICAL TRIAL TO EVALUATE THE ANTIHEMORRAGIC EFFECT OF THE TOPICAL TRANEXAMIC ACID DURING PACEMAKER IN ANTICOAGULATED PATIENTS | ||
Medical condition: Pacemaker implant for anticoagulated patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000885-39 | Sponsor Protocol Number: 02289 | Start Date*: 2021-01-12 | |||||||||||
Sponsor Name:Universitätsmedizin Göttingen | |||||||||||||
Full Title: Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure | |||||||||||||
Medical condition: Heart Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-024328-53 | Sponsor Protocol Number: HULPOFT-2010-01 | Start Date*: 2012-05-14 |
Sponsor Name:Fundación para la Investigación Biomédica del Hospital Universitario La Paz | ||
Full Title: Phase IIa clinical trial to determine the feasibility and safety of using autologous expanded stem cell (ASC) from fat in the treatment of keratopathy associated with bilateral limbic insufficiency | ||
Medical condition: Keratopathy associated with bilateral limbic insufficiency. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-001357-26 | Sponsor Protocol Number: 13-036 | Start Date*: 2014-08-04 | ||||||||||||||||
Sponsor Name:Clinical Trial Center Aachen | ||||||||||||||||||
Full Title: HIGH DOSE SUPPLEMENTATION OF SELENIUM IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) IMPLANT SURGERY – A DOUBLE BLIND RANDOMISED CONTROLLED TRIAL | ||||||||||||||||||
Medical condition: Selenium is a key component of a number of selenoproteins which protect against oxidative stress and is well recognised for its prominent role in immune defence. Selenoproteins have the potential t... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-000995-13 | Sponsor Protocol Number: DECODE-CKD | Start Date*: 2022-01-26 | |||||||||||
Sponsor Name:Department of Cardiology, Herlev and Gentofte hospital | |||||||||||||
Full Title: A 6-Month, Randomized, Double-Blind Study to Evaluate the Effect of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease (DECODE-CKD) | |||||||||||||
Medical condition: Chronic kidney disease | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006606-16 | Sponsor Protocol Number: F003MN0307_1 | Start Date*: 2008-07-11 | |||||||||||
Sponsor Name:University of Wuerzburg | |||||||||||||
Full Title: The Effects of Paricalcitol capsules on Inflammation (CRP levels) and Calcification regulation (fetuin-A levels) in CKD stage 5D patients | |||||||||||||
Medical condition: Chronic kidney disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002219-28 | Sponsor Protocol Number: 2011-002219-28 | Start Date*: 2011-12-12 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI PADOVA | |||||||||||||
Full Title: Effect of pharmacological prophylaxis with low molecular weight heparin on implantation in women undergoing assisted reproductive procedures to prevent implant failure: a prospective randomized study. | |||||||||||||
Medical condition: Inability to conceive after a year of sexual relations free from any system of contraception | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016970-33 | Sponsor Protocol Number: MACI00809 | Start Date*: 2011-03-17 | ||||||||||||||||
Sponsor Name:Genzyme Europe BV | ||||||||||||||||||
Full Title: An Extension Protocol for Participants of Genzyme-Sponsored Prospective, Randomized, Open-Label, Parallel-Group, Multicenter Study of Matrix-Induced Autologous Chondrocyte Implantation (MACI® impl... | ||||||||||||||||||
Medical condition: Symptomatic Articular Cartilage Defects of the Femoral Condyle including the Trochlea. Osteochondritis dissecans lesions that do not require a bone graft. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) CZ (Completed) GB (Completed) SE (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-002673-35 | Sponsor Protocol Number: Fos.06/2016 | Start Date*: 2017-03-29 |
Sponsor Name:PRO-IMPLANT Foundation | ||
Full Title: Efficacy and safety of intravenous fosfomycin in prosthetic joint infection (PJI) caused by staphylococci, streptococci, enterococci and gram-negative bacilli, including mixed infections and cultur... | ||
Medical condition: Prosthetic joint infection of knee, hip or shoulder | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-005394-66 | Sponsor Protocol Number: ESR-20-21070 | Start Date*: 2022-02-21 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA SENESE | |||||||||||||
Full Title: Effects of Dapagliflozin on cardiac deformation and clinical outcomes in heart failure with reduced and mildly reduced ejection fraction | |||||||||||||
Medical condition: heart failure with left ventricular ejection fraction <50% | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000726-10 | Sponsor Protocol Number: ADAPT | Start Date*: 2021-06-23 | |||||||||||
Sponsor Name:IRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI | |||||||||||||
Full Title: Evaluating the short-term renal and systemic effects of Dapagliflozin in non-diabetic patients with stage IV CKD at risk of ESKD because of severe renal insufficiency and persistent proteinuria: A ... | |||||||||||||
Medical condition: Non-diabetic stage IV Chronic Kidney Disease (CKD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000490-40 | Sponsor Protocol Number: S320.2.003 | Start Date*: 2007-06-20 | |||||||||||
Sponsor Name:Solvay Pharmaceuticals GmbH | |||||||||||||
Full Title: Randomised, Double-Blind, Placebo-Controlled, Multi-Center, Sequential Cohort Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects with C... | |||||||||||||
Medical condition: Renal Function in Subjects with Congestive Heart Failure and Impaired Renal Function who are on Chronic Furosemide Treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Prematurely Ended) ES (Ongoing) DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004625-42 | Sponsor Protocol Number: KardioPII | Start Date*: 2009-01-09 |
Sponsor Name:Asklepios Kliniken Hamburg GmbH | ||
Full Title: Percutaneous Intramyocardial Cell Therapy After Acute Myocardial Infarction using Bone Marrow Mononuclear Cells | ||
Medical condition: Acute myocardial infarction (LVEF<45%) ICD10: I21.9 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2007-003481-18 | Sponsor Protocol Number: CART.III. | Start Date*: 2008-11-17 |
Sponsor Name:TBF | ||
Full Title: PHASE III PROTOCOL COMPARING A MICROFRACTURE TREATMENT TO A CARTIPATCH® CHONDROCYTE GRAFT TREATMENT IN FEMORAL CONDYLE LESIONS | ||
Medical condition: Femoral condyles single lesion from trauma or osteochondritis dissequans with invalidant signs | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-007055-13 | Sponsor Protocol Number: CTU 043C | Start Date*: 2009-07-17 |
Sponsor Name:RIEMSER Arzneimittel AG | ||
Full Title: DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED PROSPECTIVE MULTI-CENTRE PHASE III TRIAL TO ASSESS THE EFFICACY AND SAFETY OF METHANTHELINIUM BROMIDE (VAGANTIN®) IN THE TREATMENT OF FOCAL PALMAR-AXILL... | ||
Medical condition: Treatment of patients with axillary and palmar hyperhidrosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012928-89 | Sponsor Protocol Number: 1.1042009 | Start Date*: 2009-10-21 | |||||||||||
Sponsor Name:South Tees NHS Trust | |||||||||||||
Full Title: Intrathecal injection of a single dose of Ziconotide (Prialt®) to evaluate the option of continuous administration via implanted pump. A Pilot Study | |||||||||||||
Medical condition: Severe, Chronic pain in patients who require intrathecal analgesia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.